FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3903911000001109: De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18020501000001111 De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38301801000001110 De-Noltab 120mg tablets (Astellas Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Is a Product containing precisely tripotassium dicitratobismuthate 120 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Has active ingredient Tripotassium dicitratobismuthate false Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Has active ingredient Tripotassium dicitratobismuthate false Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Is a De-Noltab true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Has specific active ingredient Tripotassium dicitratobismuthate true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) 112 tablet 14 x 8 tablets Is pack of False De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Inferred relationship Existential restriction modifier
De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) 112 tablet 14 x 8 tablets Has AMP True De-Noltab 120mg tablets (Yamanouchi Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start